MedPath

Monitoring the effects of Antihypertensives(ACE Inhibitors / ARBS)in patients undergoing surgey

Not Applicable
Completed
Conditions
Health Condition 1: I10-I16- Hypertensive diseases
Registration Number
CTRI/2020/06/025892
Lead Sponsor
Kasturba Medical College Manipal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All adult hypertensive patients, of either gender on treatment with angiotensin converting enzyme inhibitors or Angiotensin receptor blockers who are scheduled for elective surgery will be enrolled in the study.

Exclusion Criteria

PREGNANT WOMEN

AGE <18YEARS

TERMINALLY ILL

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of deviation of mean blood pressure 30% from the baseline (as recorded during preoperative visit) intraoperatively <br/ ><br>Timepoint: Baseline (preop) <br/ ><br>Immediate preop <br/ ><br>After induction <br/ ><br>After intubation 1 min <br/ ><br>2 min <br/ ><br>3 min <br/ ><br>5 min <br/ ><br>10 min <br/ ><br>15 min <br/ ><br>30 min <br/ ><br>1 hr <br/ ><br>2 hr <br/ ><br>Hourly till extubation <br/ ><br>Before extubation <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1)Incidence of deviation of mean blood pressure 30% from the baseline (as recorded during preoperative visit) postoperatively <br/ ><br>2)Need for treatment of deviation in blood pressure (with vasoconstrictors/vasodilators) intraoperatively and postoperatively <br/ ><br>3)Any other adverse event attributable to ACE inhibitor/ARB continuation/discontinuation. <br/ ><br>Timepoint: After extubation <br/ ><br>1 min <br/ ><br>5 min <br/ ><br>30 min <br/ ><br>1 hr <br/ ><br>6 hr <br/ ><br>12 hr <br/ ><br>18 hr <br/ ><br>24 hr <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath